Perspectives by the Leerink Center for Pharmacoeconomics

Perspectives by the Leerink Center for Pharmacoeconomics
Podcast Description
Welcome to Perspectives, a signature podcast series from the Leerink Center for Pharmacoeconomics. Hosted by Dr. Mel Whittington, a health economist and Head of the Center for Pharmacoeconomics, we will be hearing from individuals across the industry to better understand and appreciate the societal impact of healthcare innovations.
Podcast Insights
Content Themes
The podcast focuses on healthcare innovations, cost-effectiveness analysis, and the societal impact of health policies, with episodes including discussions on Generalized Cost Effectiveness Analysis (GCEA) and communication strategies for health impacts. Specific themes also cover the intersection of health journalism and economics.

Welcome to Perspectives, a signature podcast series from the Leerink Center for Pharmacoeconomics. Hosted by Dr. Mel Whittington, a health economist and Head of the Center for Pharmacoeconomics, we will be hearing from individuals across the industry to better understand and appreciate the societal impact of healthcare innovations.
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Kirsten Axelsen, Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute where they discuss drug prices, their opportunity costs, and the effect today’s prices have on future drug developments.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.